Roberts Wealth Advisors LLC Invests $256,000 in Danaher Co. (NYSE:DHR)

Roberts Wealth Advisors LLC purchased a new position in shares of Danaher Co. (NYSE:DHR) in the first quarter, according to its most recent filing with the Securities & Exchange Commission. The fund purchased 1,070 shares of the conglomerate’s stock, valued at approximately $256,000.

Other hedge funds and other institutional investors have also modified their holdings of the company. Cape Investment Advisory Inc. purchased a new stake in shares of Danaher during the fourth quarter worth about $25,000. Tsfg LLC grew its holdings in Danaher by 733.3% in the first quarter. Tsfg LLC now owns 100 shares of the conglomerate’s stock valued at $25,000 after purchasing an additional 88 shares during the period. BKM Wealth Management LLC purchased a new stake in Danaher in the fourth quarter valued at approximately $27,000. Wetzel Investment Advisors Inc. purchased a new stake in Danaher in the fourth quarter valued at approximately $29,000. Finally, Rakuten Securities Inc. purchased a new stake in Danaher in the fourth quarter valued at approximately $36,000. 79.05% of the stock is currently owned by hedge funds and other institutional investors.

Insider Buying and Selling at Danaher

In other Danaher news, Director Alan G. Spoon sold 708 shares of the stock in a transaction that occurred on Thursday, May 2nd. The stock was sold at an average price of $243.58, for a total transaction of $172,454.64. Following the transaction, the director now owns 116,202 shares of the company’s stock, valued at approximately $28,304,483.16. The transaction was disclosed in a document filed with the SEC, which is available at this link. In other news, Director Alan G. Spoon sold 708 shares of the stock in a transaction that occurred on Thursday, May 2nd. The stock was sold at an average price of $243.58, for a total transaction of $172,454.64. Following the sale, the director now directly owns 116,202 shares in the company, valued at approximately $28,304,483.16. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CEO Rainer Blair sold 47,175 shares of the stock in a transaction that occurred on Wednesday, April 24th. The stock was sold at an average price of $249.22, for a total value of $11,756,953.50. Following the sale, the chief executive officer now owns 115,995 shares in the company, valued at $28,908,273.90. The disclosure for this sale can be found here. Insiders have sold 148,783 shares of company stock worth $37,536,717 over the last quarter. 10.90% of the stock is owned by corporate insiders.

Danaher Trading Down 0.8 %

NYSE DHR opened at $249.85 on Monday. The company’s fifty day simple moving average is $255.96 and its 200-day simple moving average is $246.75. Danaher Co. has a 52 week low of $182.09 and a 52 week high of $269.11. The company has a current ratio of 1.85, a quick ratio of 1.51 and a debt-to-equity ratio of 0.31. The stock has a market cap of $185.06 billion, a P/E ratio of 42.35, a PEG ratio of 3.82 and a beta of 0.84.

Danaher (NYSE:DHR) last posted its quarterly earnings results on Tuesday, April 23rd. The conglomerate reported $1.92 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.72 by $0.20. The firm had revenue of $5.80 billion for the quarter, compared to analysts’ expectations of $5.62 billion. Danaher had a net margin of 16.78% and a return on equity of 11.43%. The firm’s quarterly revenue was down 2.6% on a year-over-year basis. During the same period in the prior year, the company posted $2.36 earnings per share. Equities research analysts predict that Danaher Co. will post 7.63 EPS for the current fiscal year.

Danaher Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, July 26th. Investors of record on Friday, June 28th will be issued a $0.27 dividend. This represents a $1.08 annualized dividend and a yield of 0.43%. The ex-dividend date is Friday, June 28th. Danaher’s dividend payout ratio is currently 18.31%.

Analyst Upgrades and Downgrades

A number of equities research analysts recently issued reports on the stock. Bank of America boosted their target price on shares of Danaher from $258.00 to $270.00 and gave the company a “neutral” rating in a report on Wednesday, April 24th. Jefferies Financial Group began coverage on shares of Danaher in a report on Monday, June 3rd. They issued a “buy” rating and a $295.00 target price for the company. Citigroup lifted their price target on shares of Danaher from $280.00 to $290.00 and gave the company a “buy” rating in a research report on Wednesday, April 24th. Barclays lifted their price target on shares of Danaher from $260.00 to $270.00 and gave the company an “equal weight” rating in a research report on Wednesday, April 24th. Finally, HSBC raised shares of Danaher from a “hold” rating to a “buy” rating and lifted their price target for the company from $250.00 to $280.00 in a research report on Wednesday, April 17th. Six investment analysts have rated the stock with a hold rating and ten have assigned a buy rating to the company. According to data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $269.29.

Danaher Company Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.